Genetic characteristics of drug-resistant Vibrio cholerae O1 causing endemic cholera in Dhaka, 2006-2011

Journal of Medical Microbiology

Volumn 61, Issue PART12, 2012, Pages 1736-1745

  Rashed, Shah M ^a   Mannan, Shahnewaj B ^a   Johura, Fatema tuz ^a   Tarequl Islam, M ^a   Sadique, Abdus ^a   Watanabe, Haruo ^b   Bradley Sack, R ^c   Huq, Anwar ^d   Colwell, Rita R ^c,d   Cravioto, Alejandro ^a   Alam, Munirul ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE; ERYTHROMYCIN; FURAZOLIDONE; GENOMIC DNA; TETRACYCLINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BANGLADESH; CHOLERA; CTXB GENE; ENDEMIC DISEASE; GENE MUTATION; GENOTYPE; INTEGRON; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANDEMIC; PHENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; VIBRIO CHOLERAE;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BANGLADESH; BASE SEQUENCE; BETA-LACTAMASES; CHOLERA; CIPROFLOXACIN; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENDEMIC DISEASES; ERYTHROMYCIN; FURAZOLIDONE; GENETIC VARIATION; GENTAMICINS; HUMANS; MICROBIAL SENSITIVITY TESTS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM; VIBRIO CHOLERAE O1;

EID: 84869414024     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.049635-0     Document Type: Article

References (43)

1. Alam, M., Hasan, N. A., Sadique, A., Bhuiyan, N. A., Ahmed, K. U., Nusrin, S., Nair, G. B., Siddique, A. K., Sack, R. B. & other authors (2006). Seasonal cholera caused by Vibrio cholerae serogroups O1 and O139 in the coastal aquatic environment of Bangladesh. Appl Environ Microbiol 72, 4096-4104.
2. Alam, M., Sultana, M., Nair, G. B., Siddique, A. K., Hasan, N. A., Sack, R. B., Sack, D. A., Ahmed, K. U., Sadique, A. & other authors (2007). Viable but nonculturable Vibrio cholerae O1 in biofilms in the aquatic environment and their role in cholera transmission. Proc Natl Acad Sci U S A 104, 17801-17806.
3. Alam, M., Nusrin, S., Islam, A., Bhuiyan, N. A., Rahim, N., Delgado, G., Morales, R., Mendez, J. L., Navarro, A. & other authors (2010). Cholera between 1991 and 1997 in Mexico was associated with infection by classical, El Tor, and El Tor variants of Vibrio cholerae. J Clin Microbiol 48, 3666-3674.
4. Bauer, A. W., Kirby, W. M., Sherris, J. C. & Turck, M. (1966). Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45, 493-496.
5. Chin, C. S., Sorenson, J., Harris, J. B., Robins, W. P., Charles, R. C., Jean-Charles, R. R., Bullard, J., Webster, D. R., Kasarskis, A. & other authors (2011). The origin of the Haitian cholera outbreak strain. N Engl J Med 364, 33-42.
6. Cholera working group (1993). Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Lancet 342, 387-390.
7. Chow, K. H., Ng, T. K., Yuen, K. Y. & Yam, W. C. (2001). Detection of RTX toxin gene in Vibrio cholerae by PCR. J Clin Microbiol 39, 2594-2597.
8. Chun, J., Grim, C. J., Hasan, N. A., Lee, J. H., Choi, S. Y., Haley, B. J., Taviani, E., Jeon, Y. S., Kim, D. W. & other authors (2009). Comparative genomics reveals mechanism for short-term and long-term clonal transitions in pandemic Vibrio cholerae. Proc Natl Acad Sci U S A 106, 15442-15447.
9. CLSI (2010). Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. Approved Guideline 2nd edn, document M45-A2 (ISBN 1-56238-732-4). Wayne, PA: Clinical and Laboratory Standards Institute.
10. Cooper, K. L., Luey, C. K., Bird, M., Terajima, J., Nair, G. B., Kam, K. M., Arakawa, E., Safa, A., Cheung, D. T. & other authors (2006). Development and validation of a PulseNet standardized pulsed-field gel electrophoresis protocol for subtyping of Vibrio cholerae. Foodborne Pathog Dis 3, 51-58.
11. Dziejman, M., Balon, E., Boyd, D., Fraser, C. M., Heidelberg, J. F. & Mekalanos, J. J. (2002). Comparative genomic analysis of Vibrio cholerae: genes that correlate with cholera endemic and pandemic disease. Proc Natl Acad Sci U S A 99, 1556-1561.
12. Faruque, A. S. G., Salam, M. A., Faruque, S. M. & Fuchs, G. J. (1998). Aetiological, clinical and epidemiological characteristics of a seasonal peak of diarrhoea in Dhaka, Bangladesh. Scand J Infect Dis 30, 393-396.
13. Faruque, A. S. G., Alam, K., Malek, M. A., Khan, M. G., Ahmed, S., Saha, D., Khan, W. A., Nair, G. B., Salam, M. A. & other authors (2007). Emergence of multidrug-resistant strain of Vibrio cholerae O1 in Bangladesh and reversal of their susceptibility to tetracycline after two years. J Health Popul Nutr 25, 241-243.
14. Glass, R. I., Huq, I., Alim, A. R. M. A. & Yunus, M. (1980). Emergence of multiply antibiotic-resistant Vibrio cholerae in Bangladesh. J Infect Dis 142, 939-942.
15. Glass, R. I., Huq, M. I., Lee, J. V., Threlfall, E. J., Khan, M. R., Alim, A. R., Rowe, B. & Gross, R. J. (1983). Plasmid-borne multiple drug resistance in Vibrio cholerae serogroup O1, biotype El Tor: evidence for a point-source outbreak in Bangladesh. J Infect Dis 147, 204-209.
16. Goel, A. K. & Jiang, S. C. (2010). Genetic determinants of virulence, antibiogram and altered biotype among the Vibrio cholerae O1 isolates from different cholera outbreaks in India. Infect Genet Evol 10, 815-819.
17. Greenough, W. B., III, Gordon, R. S., Jr, Rosenberg, I. S., Davies, B. I. & Benenson, A. S. (1964). Tetracycline in the treatment of cholera. Lancet 1, 355-357.
18. Hoshino, K., Yamasaki, S., Mukhopadhyay, A. K., Chakraborty, S., Basu, A., Bhattacharya, S. K., Nair, G. B., Shimada, T. & Takeda, Y. (1998). Development and evaluation of a multiplex PCR assay for rapid detection of toxigenic Vibrio cholerae O1 and O139. FEMS Immunol Med Microbiol 20, 201-207.
19. Jain, M., Goel, A. K., Bhattacharya, P., Ghatole, M. & Kamboj, D. V. (2011). Multidrug resistant Vibrio cholerae O1 El Tor carrying classical ctxB allele involved in a cholera outbreak in South Western India. Acta Trop 117, 152-156.
20. Jesudason, M. V. & John, T. J. (1990). Transferable trimethoprim resistance of Vibrio cholerae O1 encountered in southern India. Trans R Soc Trop Med Hyg 84, 136-137.
21. Kaper, J. B., Morris, J. G., Jr & Levine, M. M. (1995). Cholera. Clin Microbiol Rev 8, 48-86.
22. Kimsey, H. H., Nair, G. B., Ghosh, A. & Waldor, M. K. (1998). Diverse CTXws and evolution of new pathogenic Vibrio cholerae. Lancet 352, 457-458.
23. Kumar, P., Jain, M., Goel, A. K., Bhadauria, S., Sharma, S. K., Kamboj, D. V., Singh, L., Ramamurthy, T. & Nair, G. B. (2009). A large cholera outbreak due to a new cholera toxin variant of the Vibrio cholerae O1 El Tor biotype in Orissa, Eastern India. J Med Microbiol 58, 234-238.
24. Kumar, P., Wilson, P. A., Bhai, R. & Thomas, S. (2010). Characterization of an SXT variant Vibrio cholerae O1 Ogawa isolated from a patient in Trivandrum, India. FEMS Microbiol Lett 303, 132-136.
25. Lindenbaum, J., Greenough, W. B. & Islam, M. R. (1967). Antibiotic therapy of cholera. Bull World Health Organ 36, 871-883.
26. Maimone, F., Coppo, A., Pazzani, C., Ismail, S. O., Guerra, R., Procacci, P., Rotigliano, G. & Omar, K. H. (1986). Clonal spread of multiply resistant strains of Vibrio cholerae O1 in Somalia. J Infect Dis 153, 802-803.
27. Marin, M. A. & Vicente, A. C. (2012). Variants of Vibrio cholerae O1 El Tor from Zambia showed new genotypes of ctxB. Epidemiol Infect 140, 1386-1387, author reply 1387-1388.
28. Mhalu, F. S., Mmari, P. W. & Ijumba, J. (1979). Rapid emergence of El Tor Vibrio cholerae resistant to antimicrobial agents during first six months of fourth cholera epidemic in Tanzania. Lancet 1, 345-347.
29. Mutreja, A., Kim, D. W., Thomson, N. R., Connor, T. R., Lee, J. H., Kariuki, S., Croucher, N. J., Choi, S. Y., Harris, S. R. & other authors (2011). Evidence for several waves of global transmission in the seventh cholera pandemic. Nature 477, 462-465.
30. Naha, A., Pazhani, G. P., Ganguly, M., Ghosh, S., Ramamurthy, T., Nandy, R. K., Nair, G. B., Takeda, Y. & Mukhopadhyay, A. K. (2012). Development and evaluation of a PCR assay for tracking the emergence and dissemination of Haitian variant ctxB in Vibrio cholerae O1 strains isolated from Kolkata, India. J Clin Microbiol 50, 1733-1736.
31. Nair, G. B., Faruque, S. M., Bhuiyan, N. A., Kamruzzaman, M., Siddique, A. K. & Sack, D. A. (2002). New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh. J Clin Microbiol 40, 3296-3299.
32. Nair, G. B., Qadri, F., Holmgren, J., Svennerholm, A. M., Safa, A., Bhuiyan, N. A., Ahmad, Q. S., Faruque, S. M., Faruque, A. S. & other authors (2006). Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh. J Clin Microbiol 44, 4211-4213.
33. Olsvik, O., Wahlberg, J., Petterson, B., Uhlé n, M., Popovic, T., Wachsmuth, I. K. & Fields, P. I. (1993). Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains. J Clin Microbiol 31, 22-25.
34. Politzer, R. (1959). Cholera, pp. 11-50. Geneva, Switzerland: World Health Organization.
35. Quilici, M. L., Massenet, D., Gake, B., Bwalki, B. & Olson, D. M. (2010). Vibrio cholerae O1 variant with reduced susceptibility to ciprofloxacin, Western Africa. Emerg Infect Dis 16, 1804-1805.
36. Ramamurthy, T., Garg, S., Sharma, R., Bhattacharya, S. K., Nair, G. B., Shimada, T., Takeda, T., Karasawa, T., Kurazano, H. & other authors (1993). Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet 341, 703-704.
37. Sack, D. A., Sack, R. B., Nair, G. B. & Siddique, A. K. (2004). Cholera. Lancet 363, 223-233.
38. Safa, A., Sultana, J., Dac Cam, P., Mwansa, J. C. & Kong, R. Y. (2008). Vibrio cholerae O1 hybrid El Tor strains, Asia and Africa. Emerg Infect Dis 14, 987-988.
39. Saha, D., Karim, M. M., Khan, W. A., Ahmed, S., Salam, M. A. & Bennish, M. L. (2006). Single-dose azithromycin for the treatment of cholera in adults. N Engl J Med 354, 2452-2462.
40. Siddique, A. K., Nair, G. B., Alam, M., Sack, D. A., Huq, A., Nizam, A., Longini, I. M., Jr, Qadri, F., Faruque, S. M. & other authors (2010). El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect 138, 347-352.
41. Taneja, N., Samanta, P., Mishra, A. & Sharma, M. (2010). Emergence of tetracycline resistance in Vibrio cholerae O1 biotype El Tor serotype Ogawa from north India. Indian J Pathol Microbiol 53, 865-866.
42. Thungapathra, M., Amita, Sinha, K. K., Chaudhuri, S. R., Garg, P., Ramamurthy, T., Nair, G. B. & Ghosh, A. (2002). Occurrence of antibiotic resistance gene cassettes aac(69)-Ib, dfrA5, dfrA12, and ereA2 in class I integrons in non-O1, non-O139 Vibrio cholerae strains in India. Antimicrob Agents Chemother 46, 2948-2955.
43. Waldor, M. K., Tschä pe, H. & Mekalanos, J. J. (1996). A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139. J Bacteriol 178, 4157-4165.